| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1400096 | 重组抗淋巴细胞瘤(CD20)单抗注射液(利妥昔单抗) | rituximab | Injection | Biological Products(2) | New Drug Application | 2014-11-17 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-12-08 | view |